Overexpression of miR-361-5p in triple-negative breast cancer (TNBC) inhibits migration and invasion by targeting RQCD1 and inhibiting the EGFR/PI3K/Akt pathway. Biomol Biomed. 2019;19(1):52-59. doi:10.17305/bjbms.2018.3399